Carna Biosciences (TSE:4572) Asset Impairment Charge : 円0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Asset Impairment Charge?

Carna Biosciences's Asset Impairment Charge for the three months ended in Jun. 2024 was 円0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was 円0 Mil.

Carna Biosciences Asset Impairment Charge Historical Data

The historical data trend for Carna Biosciences's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Asset Impairment Charge Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Carna Biosciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Carna Biosciences Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Carna Biosciences Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences Headlines

No Headlines